Canada markets close in 3 hours 55 minutes

Vaxil Bio Ltd. (VXL.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.10000.0000 (0.00%)
As of 11:37AM EDT. Market open.
Currency in CAD

Valuation Measures

Market Cap (intraday) 510.45M
Enterprise Value 39.49M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)25.00
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-8.55

Trading Information

Stock Price History

Beta (5Y Monthly) -4.00
52-Week Change 3185.71%
S&P500 52-Week Change 314.13%
52 Week High 30.3350
52 Week Low 30.0250
50-Day Moving Average 30.1097
200-Day Moving Average 30.1084

Share Statistics

Avg Vol (3 month) 3588.97k
Avg Vol (10 day) 3225.56k
Shares Outstanding 5104.47M
Float 93.39M
% Held by Insiders 110.06%
% Held by Institutions 10.00%
Shares Short (Sep. 29, 2020) 466.97k
Short Ratio (Sep. 29, 2020) 40.08
Short % of Float (Sep. 29, 2020) 4N/A
Short % of Shares Outstanding (Sep. 29, 2020) 40.06%
Shares Short (prior month Aug. 30, 2020) 481.87k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:2
Last Split Date 3Mar. 09, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Jun. 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-90.62%
Return on Equity (ttm)-490.15%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -1.11M
Net Income Avi to Common (ttm)-1.17M
Diluted EPS (ttm)-0.0130
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.07M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)186k
Total Debt/Equity (mrq)44.82
Current Ratio (mrq)1.47
Book Value Per Share (mrq)0.00

Cash Flow Statement

Operating Cash Flow (ttm)-719k
Levered Free Cash Flow (ttm)-285.62k